These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 34361596)
21. Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka. Nakamura S; Murakami T; Nakamura J; Kobayashi H; Matsuda H; Yoshikawa M Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1545-50. PubMed ID: 17077551 [TBL] [Abstract][Full Text] [Related]
22. New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review. Bora AFM; Kouame KJE; Li X; Liu L; Pan Y Int J Biol Macromol; 2023 Mar; 231():123173. PubMed ID: 36642359 [TBL] [Abstract][Full Text] [Related]
23. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L. Shivanagoudra SR; Perera WH; Perez JL; Athrey G; Sun Y; Wu CS; Jayaprakasha GK; Patil BS Bioorg Med Chem; 2019 Jul; 27(14):3097-3109. PubMed ID: 31196754 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of nuclear transcription factor-κB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia. Nhiem NX; Yen PH; Ngan NT; Quang TH; Kiem PV; Minh CV; Tai BH; Cuong NX; Song SB; Kim YH J Med Food; 2012 Apr; 15(4):369-77. PubMed ID: 22248180 [TBL] [Abstract][Full Text] [Related]
25. Cucurbitane triterpenoids from Momordica charantia. Li QY; Chen HB; Liu ZM; Wang B; Zhao YY Magn Reson Chem; 2007 Jun; 45(6):451-6. PubMed ID: 17431862 [TBL] [Abstract][Full Text] [Related]
26. One new 19-nor cucurbitane-type triterpenoid from the stems of Momordica charantia. Li YC; Xu XJ; Yang J; Wu XG; Fu QY Nat Prod Res; 2016; 30(8):973-8. PubMed ID: 26539691 [TBL] [Abstract][Full Text] [Related]
27. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. Akihisa T; Higo N; Tokuda H; Ukiya M; Akazawa H; Tochigi Y; Kimura Y; Suzuki T; Nishino H J Nat Prod; 2007 Aug; 70(8):1233-9. PubMed ID: 17685651 [TBL] [Abstract][Full Text] [Related]
28. Cucurbitane-type triterpenoids from the leaves of Momordica charantia. Zhang YB; Liu H; Zhu CY; Zhang MX; Li YL; Ling B; Wang GC J Asian Nat Prod Res; 2014; 16(4):358-63. PubMed ID: 24498856 [TBL] [Abstract][Full Text] [Related]
30. Structure determination, bitterness evaluation and hepatic gluconeogenesis inhibitory activity of triterpenoids from the Momordica charantia fruit. Deng Y; Ma Y; Liu H; Zhang Y; Wei Z; Liu G; Tang X; Jia X Food Chem; 2022 Mar; 372():131224. PubMed ID: 34624787 [TBL] [Abstract][Full Text] [Related]
31. BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages. Jones LD; Pangloli P; Krishnan HB; Dia VP Phytomedicine; 2018 Mar; 42():226-232. PubMed ID: 29655690 [TBL] [Abstract][Full Text] [Related]
32. Four new cucurbitane-type triterpenes from Momordica charantia L. with their cytotoxic activities and protective effects on H Yue J; Sun Y; Xu J; Zhang X; Zhao Y J Nat Med; 2020 Jan; 74(1):34-40. PubMed ID: 31256310 [TBL] [Abstract][Full Text] [Related]
33. Chemical constituents from Kandelia candel with their inhibitory effects on pro-inflammatory cytokines production in LPS-stimulated bone marrow-derived dendritic cells (BMDCs). Dat le D; Thao NP; Tai BH; Luyen BT; Kim S; Koo JE; Koh YS; Cuong NT; Thanh NV; Cuong NX; Nam NH; Kiem PV; Minh CV; Kim YH Bioorg Med Chem Lett; 2015 Apr; 25(7):1412-6. PubMed ID: 25769817 [TBL] [Abstract][Full Text] [Related]
34. Antiaging of Cucurbitane Glycosides from Fruits of Cao X; Sun Y; Lin Y; Pan Y; Farooq U; Xiang L; Qi J Oxid Med Cell Longev; 2018; 2018():1538632. PubMed ID: 29765490 [TBL] [Abstract][Full Text] [Related]
35. Kuguacins F-S, cucurbitane triterpenoids from Momordica charantia. Chen JC; Liu WQ; Lu L; Qiu MH; Zheng YT; Yang LM; Zhang XM; Zhou L; Li ZR Phytochemistry; 2009 Jan; 70(1):133-40. PubMed ID: 19041990 [TBL] [Abstract][Full Text] [Related]
36. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Harinantenaina L; Tanaka M; Takaoka S; Oda M; Mogami O; Uchida M; Asakawa Y Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1017-21. PubMed ID: 16819222 [TBL] [Abstract][Full Text] [Related]
37. Norcucurbitane triterpenoids from the fruits of Momordica charantia var. abbreviata. Liao YW; Chen CR; Hsu JL; Lin YS; Cheng HL; Shih WL; Kuo YH; Chang CI Nat Prod Commun; 2013 Jan; 8(1):79-81. PubMed ID: 23472465 [TBL] [Abstract][Full Text] [Related]
38. Structures of new triterpenoids and cytotoxicity activities of the isolated major compounds from the fruit of Momordica charantia L. Wang X; Sun W; Cao J; Qu H; Bi X; Zhao Y J Agric Food Chem; 2012 Apr; 60(15):3927-33. PubMed ID: 22369241 [TBL] [Abstract][Full Text] [Related]
39. Kaguacidine A: a novel spirohydantoin-containing cucurbitane glycoside from vines of Huang HT; Lo IW; Lin YC; Geng-You L; Lin YS; Zhang LJ; Li TL; Liaw CC; Kuo YH Nat Prod Res; 2024 Jul; 38(13):2179-2186. PubMed ID: 36606546 [TBL] [Abstract][Full Text] [Related]
40. Diterpenoids from the soft coral Sinularia maxima and their inhibitory effects on lipopolysaccharide-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells. Thao NP; Nam NH; Cuong NX; Quang TH; Tung PT; Tai BH; Luyen BT; Chae D; Kim S; Koh YS; Kiem PV; Minh CV; Kim YH Chem Pharm Bull (Tokyo); 2012; 60(12):1581-9. PubMed ID: 23207638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]